Fig. 10
[Taken from reference (Pan et al. 2015)]
Comparative Viability of a HeLa cells and b KB cells treated with Pc, N–TiO2 NPs, and N–TiO2–Pc NPs (250 μg/mL)
Fig. 10 | Cancer Nanotechnology
[Taken from reference (Pan et al. 2015)]
Comparative Viability of a HeLa cells and b KB cells treated with Pc, N–TiO2 NPs, and N–TiO2–Pc NPs (250 μg/mL)